|
Originally published In Press as doi:10.1074/jbc.M706176200 on August 7, 2007
J. Biol. Chem., Vol. 282, Issue 39, 28431-28440, September 28, 2007
Plasma Membrane Targeting Is Essential for Rem-mediated Ca2+ Channel Inhibition*
Robert N. Correll ,
Chunyan Pang ,
Brian S. Finlin ,
Alexandria M. Dailey ,
Jonathan Satin 1, and
Douglas A. Andres 2
From the
Departments of Molecular and Cellular Biochemistry and Physiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536-0509
The small GTPase Rem is a potent negative regulator of high voltage-activated Ca2+ channels and a known interacting partner for Ca2+ channel accessory subunits. The mechanism for Rem-mediated channel inhibition remains controversial, although it has been proposed that CaV association is required. Previous work has shown that a C-terminal truncation of Rem (Rem-(1–265)) displays reduced in vivo binding to membrane-localized 2a and lacks channel regulatory function. In this paper, we describe a role for the Rem C terminus in plasma membrane localization through association with phosphatidylinositol lipids. Moreover, Rem-(1–265) can associate with 2a in vitro and 1b in vivo, suggesting that the C terminus does not directly participate in CaV association. Despite demonstrated 1b binding, Rem-(1–265) was not capable of regulating a CaV1.2- 1b channel complex, indicating that subunit binding is not sufficient for channel regulation. However, fusion of the CAAX domain from K-Ras4B or H-Ras to the Rem-(1–265) C terminus restored membrane localization and Ca2+ channel regulation, suggesting that binding and membrane localization are independent events required for channel inhibition.
Received for publication, July 26, 2007
* This work was supported by Public Health Service Grants HL072936 (to D. A. A.), HL074091 (to J. S.), and P20 RR20171 from the National Center for Research Resources, National Institutes of Health (NIH) (to D. A. A.), an American Diabetes Association Junior Faculty award (to B. S. F.), and an American Heart Association predoctoral fellowship and NIH Interdisciplinary Cardiovascular Training Grant T32 HL072743 (to R. N. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3.
1 An Established Investigator of the American Heart Association.
2 To whom correspondence should be addressed: Dept. of Molecular and Cellular Biochemistry, BBSRB Rm. B-179, University of Kentucky College of Medicine, 741 S. Limestone St., Lexington, KY 40536-0509. Tel.: 859-257-6775; Fax: 859-323-1037; E-mail: dandres{at}uky.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|